Vimarsana
Biggest News Aggregation in the World

Page 3 - Sam Salman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sam Salman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sam Salman Today - Breaking & Trending Today

Cows cause 30% of methane gas emissions, Israeli team plans to reduce it - Vimarsana News

Cows cause 30% of methane gas emissions, Israeli team plans to reduce it

Impact NRS, BGU and Volcani Center hope to increase the efficiency of cows’ guts to reduce the amount of methane produced.

Source: jpost.com
miR Scientific Hires Big-Pharma Executive Erik Johnson as New Chief Operating Officer - Vimarsana News

miR Scientific Hires Big-Pharma Executive Erik Johnson as New Chief Operating Officer

/PRNewswire/ -- miR Scientific, LLC announces the appointment of Erik Johnson, a seasoned leader in pharma and oncology, as Chief Operating Officer. This...

miR Scientific Hires Big-Pharma Executive Erik Johnson as New Chief Operating Officer - Vimarsana News

miR Scientific Hires Big-Pharma Executive Erik Johnson as New Chief Operating Officer

/PRNewswire/ -- miR Scientific, LLC announces the appointment of Erik Johnson, a seasoned leader in pharma and oncology, as Chief Operating Officer. This...

miR Scientific to Present the Award-Winning Prostate Cancer Application of its Liquid Biopsy Disease Management Platform at the Jefferies Virtual Healthcare Conference - Vimarsana News

miR Scientific to Present the Award-Winning Prostate Cancer Application of its Liquid Biopsy Disease Management Platform at the Jefferies Virtual Healthcare Conference

/PRNewswire/ -- miR Scientific, LLC, a healthcare company dedicated to transforming global cancer management by providing early and highly accurate detection,...

Errant Gene Therapeutics Becomes San Rocco Therapeutics - Vimarsana News

Errant Gene Therapeutics Becomes San Rocco Therapeutics

Errant Gene Therapeutics Becomes San Rocco Therapeutics Errant Gene Therapeutics was founded in 1993, after founder Pat Girondi's son was diagnosed with Thalassemia, a cousin disease to Sickle Cell Anemia. In 2007, with the help of researchers from Memorial Sloan Kettering, Cornell and National Institute of Health, EGT became the first entity to pass the FDA Recombinant DNA Committee for gene therapy in Sickle Cell Disease and Beta Thalassemia. EGT was the first company to get Orphan Drug Designation for Thalassemia in the US and Europe and first to produce a commercial batch (8-10 patients) ...